76 related articles for article (PubMed ID: 19621420)
1. Organic dyes as small molecule protein-protein interaction inhibitors for the CD40-CD154 costimulatory interaction.
Buchwald P; Margolles-Clark E; Kenyon NS; Ricordi C
J Mol Recognit; 2010; 23(1):65-73. PubMed ID: 19621420
[TBL] [Abstract][Full Text] [Related]
2. Effective and specific inhibition of the CD40-CD154 costimulatory interaction by a naphthalenesulphonic acid derivative.
Margolles-Clark E; Kenyon NS; Ricordi C; Buchwald P
Chem Biol Drug Des; 2010 Oct; 76(4):305-13. PubMed ID: 20636329
[TBL] [Abstract][Full Text] [Related]
3. Exploratory computational assessment of possible binding modes for small molecule inhibitors of the CD40-CD154 co-stimulatory interaction.
Ganesan L; Vidović D; Schürer SC; Buchwald P
Pharmazie; 2012 May; 67(5):374-9. PubMed ID: 22764566
[TBL] [Abstract][Full Text] [Related]
4. CD154-CD40 interactions are essential for thymus-dependent antibody production in zebrafish: insights into the origin of costimulatory pathway in helper T cell-regulated adaptive immunity in early vertebrates.
Gong YF; Xiang LX; Shao JZ
J Immunol; 2009 Jun; 182(12):7749-62. PubMed ID: 19494299
[TBL] [Abstract][Full Text] [Related]
5. Prospects for CD40-directed experimental therapy of human cancer.
Tong AW; Stone MJ
Cancer Gene Ther; 2003 Jan; 10(1):1-13. PubMed ID: 12489023
[TBL] [Abstract][Full Text] [Related]
6. Suramin inhibits the CD40-CD154 costimulatory interaction: a possible mechanism for immunosuppressive effects.
Margolles-Clark E; Jacques-Silva MC; Ganesan L; Umland O; Kenyon NS; Ricordi C; Berggren PO; Buchwald P
Biochem Pharmacol; 2009 Apr; 77(7):1236-45. PubMed ID: 19283894
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation in CD40 and its functional characterization.
Qi CJ; Zheng L; Ma HB; Fei M; Qian KQ; Shen BR; Wu CP; Vihinen M; Zhang XG
Hum Mutat; 2009 Jun; 30(6):985-94. PubMed ID: 19479954
[TBL] [Abstract][Full Text] [Related]
8. CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.
Dranitzki-Elhalel M; Huang JH; Sasson M; Rachmilewitz J; Parnas M; Tykocinski ML
Int Immunol; 2007 Apr; 19(4):355-63. PubMed ID: 17314083
[TBL] [Abstract][Full Text] [Related]
9. Determination of carbohydrate structures N-linked to soluble CD154 and characterization of the interactions of CD40 with CD154 expressed in Pichia pastoris and Chinese hamster ovary cells.
Khandekar SS; Silverman C; Wells-Marani J; Bacon AM; Birrell H; Brigham-Burke M; DeMarini DJ; Jonak ZL; Camilleri P; Fishman-Lobell J
Protein Expr Purif; 2001 Nov; 23(2):301-10. PubMed ID: 11676606
[TBL] [Abstract][Full Text] [Related]
10. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
Dejica DI; Manea EM
Roum Arch Microbiol Immunol; 2006; 65(1-2):66-74. PubMed ID: 17877113
[TBL] [Abstract][Full Text] [Related]
11. Small-molecule costimulatory blockade: organic dye inhibitors of the CD40-CD154 interaction.
Margolles-Clark E; Umland O; Kenyon NS; Ricordi C; Buchwald P
J Mol Med (Berl); 2009 Nov; 87(11):1133-43. PubMed ID: 19707732
[TBL] [Abstract][Full Text] [Related]
12. CD154/CD40-mediated expression of CD154 in endothelial cells: consequences for endothelial cell-monocyte interaction.
Wagner AH; Güldenzoph B; Lienenlüke B; Hecker M
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):715-20. PubMed ID: 14976003
[TBL] [Abstract][Full Text] [Related]
13. Interaction of calreticulin with CD40 ligand, TRAIL and Fas ligand.
Duus K; Pagh RT; Holmskov U; Højrup P; Skov S; Houen G
Scand J Immunol; 2007 Nov; 66(5):501-7. PubMed ID: 17953526
[TBL] [Abstract][Full Text] [Related]
14. Estimation of the number of CD154 molecules in membrane extracts used as a source of CD40 stimulation of human B lymphocytes.
Ducas E; Dussault N; Roy A; Dumont N; Néron S
J Immunol Methods; 2009 May; 344(2):133-7. PubMed ID: 19332074
[TBL] [Abstract][Full Text] [Related]
15. LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation.
Duhen T; Pasero C; Mallet F; Barbarat B; Olive D; Costello RT
Eur J Immunol; 2004 Dec; 34(12):3534-41. PubMed ID: 15549770
[TBL] [Abstract][Full Text] [Related]
16. CD154-CD40 interactions drive hepatocyte apoptosis in murine fulminant hepatitis.
Zhou F; Ajuebor MN; Beck PL; Le T; Hogaboam CM; Swain MG
Hepatology; 2005 Aug; 42(2):372-80. PubMed ID: 16025512
[TBL] [Abstract][Full Text] [Related]
17. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
18. CD154 and its receptors in inflammatory vascular pathologies.
Hassan GS; Merhi Y; Mourad WM
Trends Immunol; 2009 Apr; 30(4):165-72. PubMed ID: 19282242
[TBL] [Abstract][Full Text] [Related]
19. Cloning, sequence analysis and expression of ovine CD154 (CD40 ligand).
Oledzka G; Li B; William Kay G; Chomicz L; Stankiewicz M
Mol Immunol; 2007 Feb; 44(5):741-6. PubMed ID: 16777229
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma enhances interleukin 12 production in rheumatoid synovial cells via CD40-CD154 dependent and independent pathways.
Kitagawa M; Suzuki H; Adachi Y; Nakamura H; Yoshino S; Sumida T
J Rheumatol; 2001 Aug; 28(8):1764-71. PubMed ID: 11508577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
